2 studies found for:    22833546 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: carfilzomib
2 Active, not recruiting Phase 1/2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: NPI-0052

Indicates status has not been verified in more than two years